agilon health Inc (NYSE:AGL) rose 30% to $0.51, emerging as one of the top healthcare gainers.
Larimar Therapeutics (NASDAQ:LRMR) delivered one of the strongest single-session performances on the NASDAQ, rallying 61.2% to $5.95 on extraordinary trading volume of 81.03 million shares, representing a 10.49x relative volume spike. With amarket capitalizationof approximately $494.39 million (EODHD/Others data as of February 25, 2026), …
Circle Internet Group (NASDAQ:NYSE) advanced 35.47% to $83.14, with 63.85 million shares traded (7.31x relative volume). At amarket capitalizationof $19.58 billion (EODHD/Others data as of February 25, 2026), Circle offers leveraged exposure to stablecoin infrastructure and digital asset settlement networks.The stock’s performance appears aligned …
CCC Intelligent Solutions rose 25.30% to $6.34, with around 16 million shares traded.Market cap: $3.85billion (EODHD/Others data as of February 25, 2026).
CAVA (NYSE:CAVA) climbed 26.36% to $85.67, supported by 5.6x relative volume. The company now carries a $9.94 billionmarket capitalization(EODHD/Others data as of February 25, 2026) and trades at a premium multiple reflective of growth expectations.
Navitas (NASDAQ:NVTS) advanced 19.61% to $9.88, with 41.80 million shares traded (3.22x relative volume).Market cap: $2.28 billion (EODHD/Others data as of February 25, 2026).
US equity markets retreated sharply, with all major indices closing lower as trade policy uncertainty resurfaced as a dominant macro risk factor. The pullback reflects renewed investor caution following escalating tariff rhetoric and legal developments surrounding US trade measures.
Shares of Eli Lilly and Company moved higher after reports indicated that Novo Nordisk’s investigational obesity therapy CagriSema did not outperform Zepbound in comparative clinical data. The market reaction underscores how tightly equity valuations in the pharmaceutical sector are now linked to incremental clinical …
WTI crude oil futures hovered around $66.5 per barrel on Monday, close to a six-month high, as financial markets weighed two competing forces: the prospect of renewed US–Iran nuclear diplomacy and the residual risk of military escalation in the Middle East. The balance between …